Meeting of the 2018 Physical Activity Guidelines Advisory Committee, 41977-41978 [2016-15206]
Download as PDF
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 124 / Tuesday, June 28, 2016 / Notices
6. Guy Sterling on behalf of A. S., Vienna,
Virginia, Court of Federal Claims No: 16–
0551V
7. Derek Bailey on behalf of J. B., Odenton,
Maryland, Court of Federal Claims No:
16–0552V
8. Donna Williams on behalf of C. W.,
Atlanta, Georgia, Court of Federal Claims
No: 16–0553V
9. Nancy N. Relyea, Colonie, New York,
Court of Federal Claims No: 16–0555V
10. Hope O’Bannon, Rancho Cucamonga,
California, Court of Federal Claims No:
16–0556V
11. Ashley Walls on behalf of K. W.,
Martinsburg, West Virginia, Court of
Federal Claims No: 16–0557V
12. Heather Spracklen and Joe Higgins on
behalf of M. H., Stillwater, Oklahoma,
Court of Federal Claims No: 16–0559V
13. Richard Deckert, St. Louis, Missouri,
Court of Federal Claims No: 16–0562V
14. Kenneth Craig, Lebanon, Indiana, Court
of Federal Claims No: 16–0564V
15. Hunter Horsey on behalf of G. H.,
Clearwater, Florida, Court of Federal
Claims No: 16–0565V
16. Elaine Moriarty, Plymouth Meeting,
Pennsylvania, Court of Federal Claims
No: 16–0566V
17. Margaret Zamora, Cleveland, Ohio, Court
of Federal Claims No: 16–0567V
18. L. Nicole Moore, Tulsa, Oklahoma, Court
of Federal Claims No: 16–0569V
19. Renate Davison, Aurora, Colorado, Court
of Federal Claims No: 16–0571V
20. Suzanne Niedziela, Carle Place, New
York, Court of Federal Claims No: 16–
0572V
21. Paula Yost, Winchester, Virginia, Court of
Federal Claims No: 16–0573V
22. Lincoln John and Daswattie John on
behalf of K. J., Schenectady, New York,
Court of Federal Claims No: 16–0574V
23. Shari Murray, Portland, Oregon, Court of
Federal Claims No: 16–0575V
24. Susan Graney, Newport News, Virginia,
Court of Federal Claims No: 16–0578V
25. Evangeline Stavretis, Fort Wayne,
Indiana, Court of Federal Claims No: 16–
0579V
26. Dolores Smoot, Cleveland, Ohio, Court of
Federal Claims No: 16–0580V
27. Karie N. DuVernay on behalf of W. R. D.,
Charlotte, North Carolina, Court of
Federal Claims No: 16–0582V
28. Josh Swan, Nashua, New Hampshire,
Court of Federal Claims No: 16–0583V
29. Rebecca Schleif, Baraboo, Wisconsin,
Court of Federal Claims No: 16–0584V
30. Linda Bailey, Charleston, West Virginia,
Court of Federal Claims No: 16–0585V
31. Nancy Tyree, White Plains, Maryland,
Court of Federal Claims No: 16–0586V
32. Timothy Selling, Scottsdale, Arizona,
Court of Federal Claims No: 16–0588V
33. Jeffrey Schafer, Ravenna, Ohio, Court of
Federal Claims No: 16–0593V
34. Patricia Miller, Beverly Hills, California,
Court of Federal Claims No: 16–0595V
35. Leah Mims and Donelle Mims on behalf
of J. M., Deceased, Stone Mountain,
Georgia, Court of Federal Claims No: 16–
0596V
36. Robert Rhodes, Greensboro, North
Carolina, Court of Federal Claims No:
VerDate Sep<11>2014
17:49 Jun 27, 2016
Jkt 238001
16–0597V
37. Teresa Polzin, Linwood, New Jersey,
Court of Federal Claims No: 16–0598V
38. Eric Heagney, Asheville, North Carolina,
Court of Federal Claims No: 16–0601V
39. Sheila R. Young, Oneida, New York,
Court of Federal Claims No: 16–0602V
40. Jeanette Eiland, Milwaukee, Wisconsin,
Court of Federal Claims No: 16–0603V
41. Aileen Harris, Phoenix, Arizona, Court of
Federal Claims No: 16–0604V
42. Debora Brown, San Antonio, Texas, Court
of Federal Claims No: 16–0605V
43. Michele Dominianni, New City, New
York, Court of Federal Claims No: 16–
0606V
44. Catherine Cintron on behalf of E. C.,
Richmond, Virginia, Court of Federal
Claims No: 16–0608V
45. Kathleen Nolan, North Tonawanda, New
York, Court of Federal Claims No: 16–
0609V
46. John Coleman, Dallas, Texas, Court of
Federal Claims No: 16–0610V
47. Russell Green, Concord, Massachusetts,
Court of Federal Claims No: 16–0612V
48. Gilmore Wright, II, Buford, Georgia, Court
of Federal Claims No: 16–0615V
49. David Johnson, San Antonio, Texas,
Court of Federal Claims No: 16–0616V
50. Abigail Michel, Roswell, Georgia, Court
of Federal Claims No: 16–0617V
51. Melissa Goyne, Dresher, Pennsylvania,
Court of Federal Claims No: 16–0619V
52. Irene Schurley, Las Vegas, Nevada, Court
of Federal Claims No: 16–0621V
53. Deborah Marino, Newtown,
Pennsylvania, Court of Federal Claims
No: 16–0622V
54. Cheryl Zanghi, Washington, District of
Columbia, Court of Federal Claims No:
16–0625V
55. Leah Soos, Washington, District of
Columbia, Court of Federal Claims No:
16–0626V
56. Lauren Ochoa on behalf of Scarlet Ochoa,
Deceased, Seattle, Washington, Court of
Federal Claims No: 16–0627V
57. Marion Crank, Jr., Beverly Hills,
California, Court of Federal Claims No:
16–0628V
58. Mary Katherine Shadix, Beverly Hills,
California, Court of Federal Claims No:
16–0629V
59. Diane Scott, Beverly Hills, California,
Court of Federal Claims No: 16–0630V
60. Theodore Worley, Beverly Hills,
California, Court of Federal Claims No:
16–0631V
61. Melissa Larson, Baraboo, Wisconsin,
Court of Federal Claims No: 16–0633V
62. Wei-Ti Chen, New Haven, Connecticut,
Court of Federal Claims No: 16–0634V
63. Maxine Ward, Memphis, Tennessee,
Court of Federal Claims No: 16–0635V
64. Michael Miller, Washington, District of
Columbia, Court of Federal Claims No:
16–0637V
65. Jake Peters, Los Angeles, California, Court
of Federal Claims No: 16–0638V
66. Sharon G. Ortagus, Palatka, Florida, Court
of Federal Claims No: 16–0639V
67. Sarah Graham, Washington, District of
Columbia, Court of Federal Claims No:
16–0640V
68. Ronald L. Edwards, Washington, District
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
41977
of Columbia, Court of Federal Claims No:
16–0641V
69. Kellie Dovre, Farmington Hills, Michigan,
Court of Federal Claims No: 16–0642V
70. Jessica Brooks, Washington, District of
Columbia, Court of Federal Claims No:
16–0643V
71. Joan Hudgens, Dallas, Texas, Court of
Federal Claims No: 16–0644V
72. Jennifer Jefko on behalf of K.L., Chicago,
Illinois, Court of Federal Claims No: 16–
0645V
73. Marie O’Donnell, Sarasota, Florida, Court
of Federal Claims No: 16–0646V
[FR Doc. 2016–15207 Filed 6–27–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the 2018 Physical Activity
Guidelines Advisory Committee
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, U.S. Department of Health
and Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act (FACA), the
U.S. Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting of the 2018 Physical
Activity Guidelines Advisory
Committee (2018 PAGAC or Committee)
will be held. This meeting will be open
to the public.
DATES: The meeting will be held on July
14, 2016, from 8:30 a.m. E.D.T. to 11:30
a.m. E.D.T. and on July 15, 2016, from
8:00 a.m. E.D.T. to 3:15 p.m. E.D.T.
ADDRESSES: The meeting will be
accessible by webcast on the Internet or
by attendance in-person. For in-person
participants the meeting will take place
in the National Institutes of Health
(NIH) John Edward Porter Neuroscience
Research Center (PNRC), Building 35,
Seminar Room 620. The facility is
located at the NIH Main Campus at 9000
Rockville Pike, Bethesda, MD 20892.
FOR FURTHER INFORMATION CONTACT:
Designated Federal Officer, 2018
Physical Activity Guidelines Advisory
Committee, Richard D. Olson and/or
Alternate Designated Federal Officer,
Katrina L. Piercy, Ph.D., R.D., Office of
Disease Prevention and Health
Promotion (ODPHP), Office of the
Assistant Secretary for Health (OASH),
HHS; 1101 Wootton Parkway, Suite LL–
100; Rockville, MD 20852; Telephone:
(240) 453–8280. Additional information
is available at www.health.gov/
paguidelines.
SUMMARY:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28JNN1.SGM
28JNN1
asabaliauskas on DSK3SPTVN1PROD with NOTICES
41978
Federal Register / Vol. 81, No. 124 / Tuesday, June 28, 2016 / Notices
Purpose: The inaugural Physical
Activity Guidelines for Americans
(PAG), issued in 2008, represents the
first comprehensive guidelines on
physical activity issued by the federal
government. The PAG provides sciencebased advice on how physical activity
can help promote health and reduce the
risk of chronic disease. The PAG serves
as the benchmark and primary,
authoritative voice of the federal
government for providing science-based
guidance on physical activity, fitness,
and health in the United States. Five
years after the first edition of the PAG
was released, ODPHP, in collaboration
with the Centers for Disease Control and
Prevention (CDC), the National
Institutes of Health (NIH), and the
President’s Council on Fitness, Sports,
and Nutrition (PCFSN) led development
of the PAG Midcourse Report: Strategies
to Increase Physical Activity Among
Youth. The second edition of the PAG
will build upon the first edition and
provide a foundation for federal
recommendations and education for
physical activity programs for
Americans, including those at risk for
chronic disease.
The Secretary of HHS approved
establishment of the 2018 PAGAC as a
discretionary federal advisory
committee. The Committee will provide
the Department with independent,
science-based advice and
recommendations. The 2018 PAGAC
consists of a panel of experts who are
selected from the private sector.
Individuals who are selected to serve on
the 2018 PAGAC must have current
scientific knowledge in the field of
human physical activity and health
promotion or the prevention of chronic
disease.
Appointed Committee Members: As
stipulated in the charter, the 2018
PAGAC will be composed of 11–17
members. Members of the Committee
are appointed by the Secretary.
Information on Committee membership
is available at www.health.gov/
paguidelines.
Committee’s Task: The work of the
2018 PAGAC will be time-limited and
solely advisory in nature. The
Committee will develop
recommendations based on the
preponderance of current scientific and
medical knowledge using a systematic
review approach. The 2018 PAGAC will
examine the current PAG, take into
consideration new scientific evidence
and current resource documents, and
develop a report to the Secretary of HHS
that outlines its science-based advice
and recommendations for development
of the PAG, second edition. The
Committee will hold approximately five
VerDate Sep<11>2014
17:49 Jun 27, 2016
Jkt 238001
public meetings to review and discuss
recommendations. Meeting dates, times,
locations, and other relevant
information will be announced at least
15 days in advance of each meeting via
Federal Register notice. As stipulated in
the charter, the Committee will be
terminated after delivery of its final
report to the Secretary of HHS or two
years from the date the charter was
filed, whichever comes first.
Purpose of the Meeting: In accordance
with FACA and to promote
transparency of the process,
deliberations of the 2018 PAGAC will
occur in a public forum. At this
meeting, the 2018 PAGAC will be
oriented to the PAG revision process
and begin its deliberations.
Meeting Agenda: The meeting agenda
will include (a) review of operations for
the Committee members, (b) a
presentation on the history of the PAG
and how they are used, (c) presentation
on the literature review process, and (d)
plans for future Committee work.
Meeting Registration: The meeting is
open to the public. The meeting will be
accessible by webcast or by attendance
in-person. Pre-registration is required
for both web viewing and in-person
attendance. To pre-register, please visit
www.health.gov/paguidelines. To
request a special accommodation, please
email niheventapproval@mail.nih.gov.
Webcast Public Participation: After
pre-registration, individuals
participating by webcast will receive
webcast access information via email.
In-Person Public Participation and
Building Access: For in-person
participants, the meeting will be held
within the National Institutes of Health
(NIH) PNRC, Building 35, as noted
above in the ADDRESSES section. Details
regarding registration capacity and
directions will be posted on
www.health.gov/paguidelines. For inperson participants, check-in at the
registration desk onsite at the meeting is
required and will begin at 7:30 a.m.
E.D.T. each day. Please note that all
visitors must enter through the NIH
Gateway Center, which opens at 6:00
a.m. E.D.T. You will be asked to submit
to a vehicle or personal inspection and
provide a government-issued ID.
Public Comments and Meeting
Documents: Written comments from the
public will be accepted throughout the
Committee’s deliberative process;
opportunities to present oral comments
to the Committee will be provided at a
future meeting. Written public
comments can be submitted and/or
viewed at www.health.gov/paguidelines
using the ‘‘Submit Comments’’ and
‘‘Read Comments’’ links, respectively.
Documents pertaining to Committee
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
deliberations, including meeting
agendas and summaries will be
available on www.health.gov/
paguidelines, and meeting materials
will be available for public viewing at
the meeting. Meeting information,
thereafter, will continue to be accessible
online and upon request at the Office of
Disease Prevention and Health
Promotion, OASH/HHS; 1101 Wootton
Parkway, Suite LL100, Tower Building;
Rockville, MD 20852; Telephone: (240)
453–8280; Fax: (240) 453–8281.
Dated: June 22, 2016.
Don Wright,
Deputy Assistant Secretary for Health, (Office
of Disease Prevention and Health Promotion).
[FR Doc. 2016–15206 Filed 6–27–16; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Investigator Initiated
Program Project Applications (P01).
Date: July 21, 2016.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities/
Room 3G31B National Institutes of Health,
NIAID, 5601 Fishers Lane MSC 9823,
Rockville, MD 20892, (240) 669–5060,
james.snyder@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 81, Number 124 (Tuesday, June 28, 2016)]
[Notices]
[Pages 41977-41978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15206]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the 2018 Physical Activity Guidelines Advisory
Committee
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary for Health, Office of the Secretary, U.S.
Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act (FACA),
the U.S. Department of Health and Human Services (HHS) is hereby giving
notice that a meeting of the 2018 Physical Activity Guidelines Advisory
Committee (2018 PAGAC or Committee) will be held. This meeting will be
open to the public.
DATES: The meeting will be held on July 14, 2016, from 8:30 a.m. E.D.T.
to 11:30 a.m. E.D.T. and on July 15, 2016, from 8:00 a.m. E.D.T. to
3:15 p.m. E.D.T.
ADDRESSES: The meeting will be accessible by webcast on the Internet or
by attendance in-person. For in-person participants the meeting will
take place in the National Institutes of Health (NIH) John Edward
Porter Neuroscience Research Center (PNRC), Building 35, Seminar Room
620. The facility is located at the NIH Main Campus at 9000 Rockville
Pike, Bethesda, MD 20892.
FOR FURTHER INFORMATION CONTACT: Designated Federal Officer, 2018
Physical Activity Guidelines Advisory Committee, Richard D. Olson and/
or Alternate Designated Federal Officer, Katrina L. Piercy, Ph.D.,
R.D., Office of Disease Prevention and Health Promotion (ODPHP), Office
of the Assistant Secretary for Health (OASH), HHS; 1101 Wootton
Parkway, Suite LL-100; Rockville, MD 20852; Telephone: (240) 453-8280.
Additional information is available at www.health.gov/paguidelines.
SUPPLEMENTARY INFORMATION:
[[Page 41978]]
Purpose: The inaugural Physical Activity Guidelines for Americans
(PAG), issued in 2008, represents the first comprehensive guidelines on
physical activity issued by the federal government. The PAG provides
science-based advice on how physical activity can help promote health
and reduce the risk of chronic disease. The PAG serves as the benchmark
and primary, authoritative voice of the federal government for
providing science-based guidance on physical activity, fitness, and
health in the United States. Five years after the first edition of the
PAG was released, ODPHP, in collaboration with the Centers for Disease
Control and Prevention (CDC), the National Institutes of Health (NIH),
and the President's Council on Fitness, Sports, and Nutrition (PCFSN)
led development of the PAG Midcourse Report: Strategies to Increase
Physical Activity Among Youth. The second edition of the PAG will build
upon the first edition and provide a foundation for federal
recommendations and education for physical activity programs for
Americans, including those at risk for chronic disease.
The Secretary of HHS approved establishment of the 2018 PAGAC as a
discretionary federal advisory committee. The Committee will provide
the Department with independent, science-based advice and
recommendations. The 2018 PAGAC consists of a panel of experts who are
selected from the private sector. Individuals who are selected to serve
on the 2018 PAGAC must have current scientific knowledge in the field
of human physical activity and health promotion or the prevention of
chronic disease.
Appointed Committee Members: As stipulated in the charter, the 2018
PAGAC will be composed of 11-17 members. Members of the Committee are
appointed by the Secretary. Information on Committee membership is
available at www.health.gov/paguidelines.
Committee's Task: The work of the 2018 PAGAC will be time-limited
and solely advisory in nature. The Committee will develop
recommendations based on the preponderance of current scientific and
medical knowledge using a systematic review approach. The 2018 PAGAC
will examine the current PAG, take into consideration new scientific
evidence and current resource documents, and develop a report to the
Secretary of HHS that outlines its science-based advice and
recommendations for development of the PAG, second edition. The
Committee will hold approximately five public meetings to review and
discuss recommendations. Meeting dates, times, locations, and other
relevant information will be announced at least 15 days in advance of
each meeting via Federal Register notice. As stipulated in the charter,
the Committee will be terminated after delivery of its final report to
the Secretary of HHS or two years from the date the charter was filed,
whichever comes first.
Purpose of the Meeting: In accordance with FACA and to promote
transparency of the process, deliberations of the 2018 PAGAC will occur
in a public forum. At this meeting, the 2018 PAGAC will be oriented to
the PAG revision process and begin its deliberations.
Meeting Agenda: The meeting agenda will include (a) review of
operations for the Committee members, (b) a presentation on the history
of the PAG and how they are used, (c) presentation on the literature
review process, and (d) plans for future Committee work.
Meeting Registration: The meeting is open to the public. The
meeting will be accessible by webcast or by attendance in-person. Pre-
registration is required for both web viewing and in-person attendance.
To pre-register, please visit www.health.gov/paguidelines. To request a
special accommodation, please email niheventapproval@mail.nih.gov.
Webcast Public Participation: After pre-registration, individuals
participating by webcast will receive webcast access information via
email.
In-Person Public Participation and Building Access: For in-person
participants, the meeting will be held within the National Institutes
of Health (NIH) PNRC, Building 35, as noted above in the ADDRESSES
section. Details regarding registration capacity and directions will be
posted on www.health.gov/paguidelines. For in-person participants,
check-in at the registration desk onsite at the meeting is required and
will begin at 7:30 a.m. E.D.T. each day. Please note that all visitors
must enter through the NIH Gateway Center, which opens at 6:00 a.m.
E.D.T. You will be asked to submit to a vehicle or personal inspection
and provide a government-issued ID.
Public Comments and Meeting Documents: Written comments from the
public will be accepted throughout the Committee's deliberative
process; opportunities to present oral comments to the Committee will
be provided at a future meeting. Written public comments can be
submitted and/or viewed at www.health.gov/paguidelines using the
``Submit Comments'' and ``Read Comments'' links, respectively.
Documents pertaining to Committee deliberations, including meeting
agendas and summaries will be available on www.health.gov/paguidelines,
and meeting materials will be available for public viewing at the
meeting. Meeting information, thereafter, will continue to be
accessible online and upon request at the Office of Disease Prevention
and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100,
Tower Building; Rockville, MD 20852; Telephone: (240) 453-8280; Fax:
(240) 453-8281.
Dated: June 22, 2016.
Don Wright,
Deputy Assistant Secretary for Health, (Office of Disease Prevention
and Health Promotion).
[FR Doc. 2016-15206 Filed 6-27-16; 8:45 am]
BILLING CODE 4150-32-P